Q Founder Seminar: Insurance 101: Managing Risk Throughout the Life Sciences Lifecycle
This will be an in-person seminar at the Querrey InQbation Lab. Lunch will be provided.
As a life sciences company moves from early research through fundraising, clinical trials, commercialization, and growth, its risks—and insurance needs—evolve. This seminar will explore the key risks founders and leadership teams should consider at each stage and how to build an insurance program that grows alongside the company.
Lori Moreno and Nick Napolitano of HUB International will discuss common insurance requirements associated with fundraising, leases, contracts, and clinical trials, as well as key coverages including products and professional liability, directors and officers (D&O) liability, cyber, and clinical trial liability. They will also address international and supply chain risks and highlight common insurance pitfalls for emerging life sciences companies.
Participants will gain a practical understanding of when different types of coverage become relevant and how insurance can help manage risk as a company advances from the lab toward the market.
This is a closed in-person event, open to the Northwestern community (students, staff, faculty and affiliated startups).
Please register using your university or startup email address.
About the Speakers:
Nicholas Napolitano is a Senior Vice President and team leader of HUB International’s Life Sciences & Technology practice. He has more than 10 years of insurance and risk management experience, with a focus on life sciences, medical device, biotechnology, and technology companies. Nick works with organizations ranging from early-stage startups to established commercial companies, advising on areas including clinical trials and product liability, directors and officers liability, cyber, property, supply chain, and international insurance programs.
Lori Moreno is a Senior Vice President and Life Sciences Practice Leader with HUB International, specializing in risk management and insurance solutions for life sciences companies. She has more than two decades of insurance industry experience and has worked extensively with biotechnology, pharmaceutical, and medical device organizations throughout their development—from early-stage companies through clinical trials and commercialization. Her background includes both underwriting and brokerage leadership, giving her a broad perspective on how life sciences companies can effectively manage and transfer risk.